Literature DB >> 30450761

Nanocarriers and Their Loading Strategies.

Neng Wang1, Xuejun Cheng1, Nan Li1, Hong Wang1, Hongyu Chen1.   

Abstract

Nanocarriers are of paramount significance for drug delivery and nanomedicine technology. Given the imperfect systems and nonideal therapeutic effects, there are works to be done in synthesis as much as in biological studies, if not more so. Building the foundation of synthesis would offer more tools and deeper insights for exploring the biological systems with extreme complexity. This review aims at a broad-scope summary and classification of nanocarriers for drug delivery, with focus on the synthetic strategy and structural implications. The nanocarriers are divided into four categories according to the loading principle: molecular-level loading, surface loading, matrix loading, and cavity loading systems. Making comparisons across diverse nanocarrier systems would make it easier to see the fundamental characteristics, from where the weakness can be addressed and the strengths combined. The systematic comparisons may also inspire new ideas and methods.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  controlled release; drug delivery; loading content; nanocarriers; nanosynthesis

Mesh:

Substances:

Year:  2018        PMID: 30450761     DOI: 10.1002/adhm.201801002

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  20 in total

Review 1.  Reactive Oxygen Species-Regulating Strategies Based on Nanomaterials for Disease Treatment.

Authors:  Chenyang Zhang; Xin Wang; Jiangfeng Du; Zhanjun Gu; Yuliang Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-12-20       Impact factor: 16.806

Review 2.  Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review.

Authors:  Josephine Oluwagbemisola Tella; Joseph Adeyemi Adekoya; Kolawole Oluseyi Ajanaku
Journal:  R Soc Open Sci       Date:  2022-06-08       Impact factor: 3.653

Review 3.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

4.  Doxorubicin-Loaded Physalis Mottle Virus Particles Function as a pH-Responsive Prodrug Enabling Cancer Therapy.

Authors:  He Hu; Nicole F Steinmetz
Journal:  Biotechnol J       Date:  2020-10-08       Impact factor: 4.677

Review 5.  Nanobottles for Controlled Release and Drug Delivery.

Authors:  Jichuan Qiu; Jianchang Xu; Younan Xia
Journal:  Adv Healthc Mater       Date:  2020-06-16       Impact factor: 9.933

Review 6.  Silver Nanoparticles as Carriers of Anticancer Drugs for Efficient Target Treatment of Cancer Cells.

Authors:  Helena I O Gomes; Catarina S M Martins; João A V Prior
Journal:  Nanomaterials (Basel)       Date:  2021-04-09       Impact factor: 5.076

7.  Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application.

Authors:  Kalaivani Buskaran; Mohd Zobir Hussein; Mohamad Aris Mohd Moklas; Mas Jaffri Masarudin; Sharida Fakurazi
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 8.  Applications of capillary action in drug delivery.

Authors:  Xiaosi Li; Yue Zhao; Chao Zhao
Journal:  iScience       Date:  2021-07-01

Review 9.  Mesoporous Silica Particles as Drug Delivery Systems-The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes.

Authors:  Katarzyna Trzeciak; Agata Chotera-Ouda; Irena I Bak-Sypien; Marek J Potrzebowski
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

10.  Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma.

Authors:  Yuexin Cui; Jiejie Sun; Wenyan Hao; Mengyu Chen; Yingzi Wang; Fenghua Xu; Chunsheng Gao
Journal:  Front Oncol       Date:  2020-10-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.